Your Navigation:PCAR > Abstract
Search pcar
检索项:
检索词:
Abstract
Pharmaceutical Care and Research: 2017; 17(6):440-444
DOI: 10.5428/pcar20170613
Stability of rabeprazole sodium injection produced by different manufacturers after dispensation as an intravenous fluid
1. YANG Ting(Department of Pharmacy,Changhai Hospital,Second Military Medical University,Shanghai 200433,China dddmyy@126.com)
2. GAO Shen(Department of Pharmacy,Changhai Hospital,Second Military Medical University,Shanghai 200433,China ggss99@126.com)
3. WANG Zhuo(Department of Pharmacy,Changhai Hospital,Second Military Medical University,Shanghai 200433,China )
4. ZHANG LiJuan(Department of Pharmacy,Changhai Hospital,Second Military Medical University,Shanghai 200433,China )
ABSTRACT  Objective: To investigate the stability of rabeprazole sodium injection (RSI) produced by different manufacturers after dispensation as an intravenous fluid,so as to provide reference for safe medication.Methods: After dispensation as an intravenous fluid,the effects of illumination,temperature and storage time on pH values,insoluble particle numbers,contents,solution color and clarity of RSI were compared between the injections produced by 3 manufacturers.Results and Conclusion: There were differences in the stability of the products by the 3 manufacturers,and the product made by the Jiangsu A Pharmaceutical Corporation,Limited displayed better stability.
Welcome to PCAR! You are the number 249 reader of this article!
Please cite this article as:
YANG Ting,GAO Shen,WANG Zhuo,ZHANG LiJuan,. Stability of rabeprazole sodium injection produced by different manufacturers after dispensation as an intravenous fluid[J]. Pharmaceutical Care and Research / yao xue fu wu yu yan jiu. 2017; 17(6): 440-444.
References:
1. State Pharmacopeia Committee.Pharmacopoeia of the People’s Republic of China.2015 ed.Volume 4[S].Beijing:Chinese Medical Science Press,2015:77-78,111-115.In Chinese.
2. TANG SuFang.Study on the sources,risks and preventive measures of insoluble particulate matters in intravenous injection[J].Tianjin Pharm,2008,20(5):65-68.In Chinese with English abstract.
3. HUANG Fang,XIANG DeShang.Determination of the content rabeprazole sodium injection by HPLC[J].J Mathemat Med,2009,22(5):584-586.In Chinese with English abstract.
4. ZHAO Jun,CHEN XiangFeng,TANG YanPing.HPLC determination of rabeprazole sodium injection and its related substances[J].Chin J Pharm Anal,2009,29(3):423-426.In Chinese with English abstract.
5. SUN Ling,WANG JinHu,BAI WanJun,et al.RP-HPLC determination of rabeprazole sodium injection and its related substances[J].Chin J Pharm Anal,2009,29(12):2134-2136.In Chinese with English abstract.
6. LIU LiuCheng,ZHAO Jun.Compatible stabilty of rabeprazole sodium injection and commonly used infusions in clinical uses[J].China Pharmacist,2009,12(1):75-77.In Chinese with English abstract.
《药学服务与研究》杂志社 All Rights Reserved 网站备案号:鲁B2-20061008
·地址:上海市杨浦区长海路168号18号楼东三楼 邮政编码:200433
·联系电话(传真):86-21-65519829, 021-31162330
·电子邮件:PharmCR@vip.163.com
·技术支持:中国康网
管理员入口